Immediate Impact
51 standout
Citing Papers
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
2023 Standout
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Works of Melenda Jeter being referenced
Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial
2017
Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small–Cell Lung Cancer and Its Effects on Survival
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Melenda Jeter | 1164 | 597 | 347 | 469 | 50 | 1.6k | |
| D. Ash | 894 | 463 | 225 | 282 | 59 | 1.6k | |
| Hong Ryull Pyo | 583 | 360 | 524 | 298 | 36 | 1.4k | |
| Sergio Faria | 1192 | 774 | 207 | 506 | 90 | 1.7k | |
| Jesmin Shafiq | 503 | 588 | 490 | 789 | 43 | 1.6k | |
| Joseph P. Concannon | 923 | 278 | 587 | 332 | 42 | 1.5k | |
| Marc-André Mahé | 749 | 340 | 377 | 535 | 88 | 1.3k | |
| Kayoko Tsujino | 1242 | 562 | 446 | 719 | 71 | 1.8k | |
| Graeme Morgan | 639 | 258 | 457 | 483 | 42 | 1.5k | |
| H. Choy | 1450 | 509 | 969 | 331 | 109 | 2.0k | |
| B. Littbrand | 730 | 470 | 357 | 676 | 54 | 1.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...